Does TOFACITINIB Cause Death neonatal? 113 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Death neonatal have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
113
Reports of Death neonatal with TOFACITINIB
0.1%
of all TOFACITINIB reports
113
Deaths
12
Hospitalizations
How Dangerous Is Death neonatal From TOFACITINIB?
Of the 113 reports, 113 (100.0%) resulted in death, 12 (10.6%) required hospitalization, and 28 (24.8%) were considered life-threatening.
Is Death neonatal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Death neonatal?
ACETAMINOPHEN (124)
ABATACEPT (123)
FOLIC ACID (122)
HYDROXYCHLOROQUINE (121)
ADALIMUMAB (120)
DICLOFENAC (120)
LEFLUNOMIDE (119)
INFLIXIMAB (118)
RITUXIMAB (118)
DESOXIMETASONE (117)
Which TOFACITINIB Alternatives Have Lower Death neonatal Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN